1. Reeves GEM, Boyle MJ, Bonfied J, Dobson P, Loewenthal M. Impact of hydroxychloroquine on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J. 2004;34:182-6.

2. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, BallmerWeber B, et al. The EAACI/GA(2)LEN/EDF/WAO guidelines for the definition, classification, diagnosis, and management of urticaria. Allerg. 2018;73:1393-414.

3. Devaux CA, Rolain JM, Colson P, Raoult D. Nw insights on the antiviral effects of chloroquine against coronavirus: what to expect for Covid-19? J Antimicrob Agents. 2020; Epub ahead of print.

4. Li F. Structure, function, and evolution of Coronavirus spike. Annu Rev Virol. 2016;3:237-61.

5. Zhou D, Dai AM, Tong Q. Covid-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020; Epub ahead of print.

6. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitor in patients with Covid-19. N England J Med. 2020; Epub ahead of print.

7. Jan Dansen AH, Epstein M, Batlle D. Renin-angiotensin system blockers and the Covid-19 pandemic. Hypertension. 2020; Epub ahead of print.

8. South AM, Diz D, Chappell MC. COVID-19, ACE2 and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020; Epub ahead of print.

9. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, et al. Intracellular transport of class II MHC molecules directed by invariant chain. Nature. 1990;348:600-5.

10. Schrezenmeier E, Dörner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16:155-66.